Buy & Sell Adaptive Biotechnologies Corp (ADPT) – Adaptive Biotechnologies Corp Price Today
Aura AI Summary
Key Stats
- $2.05BMarket Cap
- HealthSector
- -24.61%3M Drawdown
- $1.91BEnterprise Value
- -Dividend Yield
- 33 daysTypical Hold Time
Adaptive Biotechnologies Corp (ADPT) is currently valued at a market capitalization of $2.05B, with an enterprise value of $1.91B. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $8.84 and a high of $20.46, highlighting its annual price range. Over the past three months, Adaptive Biotechnologies Corp has recorded a drawdown of -24.61%, reflecting recent price volatility. On average, investors hold Adaptive Biotechnologies Corp for approximately 33 days, indicating typical investor behavior on the platform.
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Most Recent News
Bill C-22 risks harming Quebec's tech economy by driving away investments and data centers.
Bill C-22 in Canada faces strong opposition from tech leaders and experts who warn it threatens the digital economy by undermining data privacy and encryption. Quebec's tech sector, especially in AI and cloud infrastructure, could lose investments, t...
Bill C-22 sparks global tech backlash over risks to Canada's digital economy and privacy.
Canada's proposed Bill C-22 faces strong opposition from major tech firms like Meta, Apple, and Signal, as well as VPN providers, due to concerns it could force companies to weaken encryption and compromise digital privacy. Industry leaders warn this...
Ideal Power sees $300M sales funnel growth driven by AI data center demand for B-TRAN tech
Ideal Power Inc reported a significant increase in its sales opportunity funnel from $200 million to over $300 million, driven by growing demand for its B-TRAN semiconductor technology in AI data centers and energy infrastructure modernization. The c...
